Brown Ronald S, Farquharson Andre A
Dr. Brown is a professor, Division of Oral Diagnosis and Radiology, Department of Comprehensive Dentistry, College of Dentistry, Howard University, Washington, and a clinical associate professor, Department of Otolaryngology-Head and Neck Surgery, Georgetown University Medical Center, Washington. Address correspondence to Dr. Brown at the Division of Oral Diagnosis and Radiology, Department of Comprehensive Dentistry, College of Dentistry, Howard University, 600 W St., NW, Washington, D.C. 20059, e-mail
Dr. Farquharson is an associate professor, Division of Oral Diagnosis and Radiology, Department of Comprehensive Dentistry, College of Dentistry, Howard University, Washington.
J Am Dent Assoc. 2014 Nov;145(11):1141-5. doi: 10.14219/jada.2014.88.
Imiquimod (IMI) is a topical immune response modifier used in the treatment of actinic keratosis and cheilitis. Actinic cheilitis is a potentially premalignant condition that requires therapeutic intervention. IMI therapy is noted for producing cutaneous and mucosal adverse effects. The authors report the case of an 88-year-old woman who was treated for actinic cheilitis of the upper lip with IMI and who consequently experienced an oral mucosal lichenoid reaction of the lower lip and right buccal mucosa.
The patient was treated successfully with high-dose steroid therapy, and the oral lesions resolved in 17 days.
To our knowledge, this is the first case report regarding an IMI-induced oral mucosal lichenoid reaction. Clinicians should be aware of the potential of IMI to cause lichenoid reactions.
IMI is an efficacious therapeutic agent when used in the treatment of actinic cheilitis, but it is prone to cause oral mucosal side effects such as lichenoid reactions. Therefore, it is important for dentists to be knowledgeable concerning potential mucosal IMI side effects.
咪喹莫特(IMI)是一种用于治疗光化性角化病和唇炎的局部免疫反应调节剂。光化性唇炎是一种潜在的癌前病变,需要进行治疗干预。咪喹莫特治疗以产生皮肤和黏膜不良反应而闻名。作者报告了一例88岁女性患者,该患者因上唇光化性唇炎接受咪喹莫特治疗,随后下唇和右侧颊黏膜出现口腔黏膜苔藓样反应。
患者接受高剂量类固醇治疗后成功治愈,口腔病变在17天内消退。
据我们所知,这是首例关于咪喹莫特诱发口腔黏膜苔藓样反应的病例报告。临床医生应意识到咪喹莫特引起苔藓样反应的可能性。
咪喹莫特用于治疗光化性唇炎时是一种有效的治疗药物,但它容易引起口腔黏膜副作用,如苔藓样反应。因此,牙科医生了解咪喹莫特潜在的黏膜副作用很重要。